Here's Why Alder Biopharmaceuticals Inc Stock Is Bouncing Back
Investors in Alder Biopharmaceuticals (NASDAQ: ALDR) are having another wild day. Shares of the clinical-stage biopharma rose as much as 15.5% on Thursday after the company released the pricing details of its just announced common-stock offering. As of 12:43 p.m. EDT, the stock was up 13.7%.
Alder stated that it is selling 15 million shares of its common stock for $10 each. In addition, the underwriters of the deal have been granted a 30-day option to purchase up to 2.25 million additional shares at the offering price. The deal is expected to close early next week and could add up to $172.5 million to the company's bank account before subtracting fees.
Image source: Getty Images.
Source: Fool.com
Eli Lilly Corp. Stock
€749.00
-1.170%
With 62 Buy predictions and 1 Sell predictions Eli Lilly Corp. is one of the favorites of our community.
As a result the target price of 824 € shows a slightly positive potential of 10.01% compared to the current price of 749.0 € for Eli Lilly Corp..
